New Hope for Early Alzheimer's | Topeka News

Stormont Vail Health is now offering Kisunla, a groundbreaking FDA-approved treatment for early Alzheimer’s and mild cognitive impairment, designed to slow brain decline by clearing amyloid plaque—without reversing lost memories. Given as monthly infusions with MRI monitoring, it’s not a cure but a powerful tool to preserve independence. Ideal for early-stage patients with confirmed plaque, it’s shown up to 20% disease slowing in 18 months. Don’t ignore early memory changes—get screened free for adults over 50. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6b2346516e6de105